Turn Therapeutics Inc.

Public companies file this within four business days when something important happens that investors should know about before the next quarterly report.

Turn Therapeutics Inc. filed this to release information to investors under Regulation FD — usually a press release, conference presentation, or other event the company considers important. htm PRESS RELEASE, DATED JUNE 1, 2026 Exhibit 99. 1 Turn Therapeutics Reports Interim Analysis Findings and Adaptive Optimization Strategy from Phase 2 GX-03 Trial in Moderate-to-Severe Atopic Dermatitis 92.